Target Price | $261.29 |
Price | $262.54 |
Deviation |
0.47%
register free of charge
|
Number of Estimates | 17 |
17 Analysts have issued a price target CME Group a 2026 .
The average CME Group a target price is $261.29.
This is
0.47%
register free of charge
$290.00
10.46%
register free of charge
$212.00
19.25%
register free of charge
|
|
A rating was issued by 20 analysts: 8 Analysts recommend CME Group a to buy, 9 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2026 of
0.47%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 6.13 | 6.44 |
9.88% | 5.13% | |
EBITDA Margin | 69.63% | 71.37% |
2.54% | 2.50% | |
Net Margin | 56.73% | 58.29% |
0.67% | 2.76% |
15 Analysts have issued a sales forecast CME Group a 2025 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an CME Group a EBITDA forecast 2025. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 CME Group a Analysts have issued a net profit forecast 2025. The average CME Group a net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 9.67 | 10.45 |
9.14% | 8.07% | |
P/E | 25.13 | |
EV/Sales | 14.81 |
7 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
Analyst Rating | Date |
---|---|
Locked
B of A Securities:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 19 2025 |
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Feb 14 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Feb 13 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 13 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.